Kolkata, Dec 21 (UNI) MyGate has collaborated with I2Cure to secure its 15,000

gated communities against the pandemic spread.

I2cure’s patented BioShield Antiseptic Lotion, a single-use, broad-spectrum

antimicrobial that offers the protection of iodine against COVID-19 for six hours

at a stretch, is a significant step up from existing alcohol-based solutions, which

are merely disinfectants, a company official on Monday said.

While the global launch of I2Cure’s solution is planned in January 2021,

MyGate, recognising the superficial nature of disinfectants and their limited

usefulness, is bringing this state-of-the-art solution to all its societies across

India ahead of time. The collaboration will see MyGate assisting gated

communities to strengthen their protection against the virus.

Elaborating on the initiative, Abhishek Kumar, COO & Co-founder, MyGate,

says, “With the MyGate collaboration, gated communities can now get direct

access to I2Cure BioShield. It is a matter of pride for us to enable this for our

communities, who, in turn, have already shown strong interest in using the

product to break the transmission chain. This movement has the potential to

dramatically slow down the spread of virus in urban India.”

Ramesh Menon, Director - Marketing Strategy & Distribution, I2Cure, says,

“Our product is currently the most effective COVID-19 preventive available to

the masses, and we are happy to partner with MyGate to bring it to the gates

of its 15,000 communities, to ensure the safety of the millions that reside therein

as well as the millions of people, from daily help to delivery executives, that visit

them on a daily basis.”

With education institutions and offices closed and public transport drastically

reduced, gated communities are among the most active congregations and remain

potential hotspots for the virus. The majority of housing societies are taking

numerous precautions - ensuring that visitors and staff wear masks, running a

temperature check at the entry point - but virus transmission via surface remains

a major concern. With the BioShield, housing societies can protect themselves

from this risk to a great extent, enabling life to return to near normal within the

society.

While sanitisers offer protection only on application, BioShield’s molecular

iodine solution percolates under the skin, acting as a shield against any virus

and germs for six hours at a time. With a single application at the gate or at

their homes residents can be protected from the possibility of being infected

by the virus. This will result in a significant drop in the potential number of

virus carriers and breaking the chain of pandemic transmission. I2cure has

been tested and certified effective by Intertekk labs USA.

The product’s development has been guided by Dr. Jack Kessler, whose

more than 2-decade-old research into molecular iodine has led to several

advancements in the field and the successful development of I2Cure without

the negative characteristics of staining, irritation, toxicity and the risk of

acidosis. In addition to a global launch, I2cure is currently in discussion

with public health bodies for mass distribution of the BioShield.

During the pandemic, MyGate has introduced a number of new features

and inked partnerships to enhance the safety of the 2.5 million families that

reside in its communities.

UNI BM SJC